Penumbra, Inc. Share Price

Penumbra, Inc. Share Price

NYSE: PEN | Large Cap
$318.72
-$2.88 (-0.9%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Penumbra, Inc. Stock Performance

Open
$320.68
Prev. Close
$321.60
Circuit Range
N/A
Day Range
$318.36 - $321.50
Year Range
$221.33 - $362.39
Volume
18,129
Average Traded
$319.52

Penumbra, Inc. Share Price Today

As of 1 November 2026, Penumbra, Inc.'s share price is $318.72. The stock opened at $320.68, compared to its previous close of $321.60. During today's trading session, Penumbra, Inc.'s share price traded between $318.36 and $321.50, with an average price of $319.93. Over the past 52 weeks, the stock has recorded a high of $362.39 and a low of $221.33. In terms of performance, Penumbra, Inc.'s share price has declined by 2.35% over the last six months and is up 40.27% on a year-on-year basis.

Penumbra, Inc. Share Price Chart

Line chart of the Penumbra, Inc. price trend over the selected period. The price fell overall, ranging from 318.33 to 320.47, ending at 318.72.
$318.36$321.50
L
Show Current Price
H

Penumbra, Inc. Stock Fundamentals & Key Indicators

Market Cap
$12.40B
PE Ratio (TTM)
80.06
Dividend Yield
0.00%
EPS (TTM)
$3.98
Revenue (TTM)
$1.40T
Return On Equity (TTM)
9.92%
Profit Margin
12.66%
Debt to Equity
0.01
Quarterly Earnings Growth YoY
-10.69%

Penumbra, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$385.39$374.76$390.05$410.15
Net Profit$47.34$32.58$34.81$42.28
Net Profit Margin12.28%8.69%8.92%10.31%
Income ChangeN/A-31.18%6.84%21.46%

Penumbra, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$847.13$1058.52$1194.62$1403.67
Net Profit-$2.00$90.95$14.01$177.69
Net Profit Margin-0.24%8.59%1.17%12.66%
Income ChangeN/A4647.50%-84.60%1168.31%

About Penumbra, Inc.

Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.

Penumbra, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$318.51
$318.66
+0.06%
Sep 2026
$322.54
$318.48
-0.93%
Aug 2026
$322.12
$321.46
+0.11%
Jul 2026
$317.10
$321.11
+1.78%
Jun 2026
$318.86
$315.50
-0.87%
May 2026
$326.22
$318.27
-2.49%
Apr 2026
$329.01
$326.40
-0.53%
Mar 2026
$342.51
$328.14
-4.70%
Feb 2026
$358.82
$344.34
-3.91%
Jan 2026
$310.10
$358.34
+15.10%
Dec 2025
$294.02
$311.34
+6.28%
Nov 2025
$224.74
$292.95
+28.93%

PEN Share Price FAQs